• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Sanuwave

MedTech 100 roundup: Up-and-down week for industry

August 17, 2020 By Sean Whooley

Medtech stocks highlighted the topsy-turvy nature of the market last week, but ultimately finished the seven days nearly unchanged. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.77 points at the end of last week (Aug. 14). Overall, medtech stocks saw a 0.13% increase from the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: becton dickinson, Celularity, coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Hologic, Livongo, MedTech 100 Index, Medtronic, Qiagen N.V., Quidel Corp., Sanuwave, Senseonics, Thermo Fisher Scientific, Ventec Life Systems, Vingroup

Sanuwave completes Celarity buy

August 13, 2020 By Sean Whooley

Sanuwave Health (OTC:SNWV) announced that it completed its acquisition of Celularity’s UltraMist ultrasound healing therapy platform. In June, the companies announced an exclusive agreement for the purchase, which includes exclusive partnership rights for Celularity’s wound care biologic products. Celularity develops allogeneic cellular therapies engineered from postpartum human placenta, in cancer, infectious disease and degenerative disease. Along with the […]

Filed Under: Business/Financial News, Imaging, Mergers & Acquisitions, Ultrasound, Wall Street Beat, Wound Care Tagged With: Celularity, Sanuwave, SANUWAVE Health Inc.

Sanuwave announces intent to acquire Celularity’s UltraMist

June 11, 2020 By Sean Whooley

Sanuwave Health (OTC:SNWV) announced that it entered into an exclusive agreement to acquire Celularity’s UltraMist ultrasound healing therapy platform. The non-binding letter of intent includes the acquisition of UltraMist and exclusive partnership rights for Celularity’s wound care biologic products, according to a news release. Celularity develops allogeneic cellular therapies engineered from postpartum human placenta, in cancer, […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Ultrasound, Wound Care Tagged With: Celularity, Sanuwave, SANUWAVE Health Inc.

Sanuwave partners with The Mobile Health Company

May 19, 2020 By Sean Whooley

Sanuwave Health announced that it is partnering with its former president’s new business, The Mobile Health Company (MHC). Former Sanuwave president Shri Parikh launched MHC as a mobile solution for wound care and other treatments to be streamlined directly to a patient’s home setting. In launching MHC, Shri is resigning from Sanuwave, but will remain […]

Filed Under: Business/Financial News, Wound Care Tagged With: Mobile Health Company, Sanuwave, SANUWAVE Health Inc.

Sanuwave confirms acting CEO Richardson as company head | Personnel Moves – December 12, 2018

December 12, 2018 By Fink Densford

Sanuwave said late last month that it lifted acting CEO and board chair Kevin Richardson to a permanent position in the corner office. Richardson joined the Suwanee, Ga.-based company in 2009 as board chair, and has served as acting CEO since 2014. He also served as managing partner of investment management firm Prides Capital from […]

Filed Under: Business/Financial News, Featured Tagged With: Bose Corp., Bristol-Myers Squibb Co., Common Sensing, glympsebio, INSIGHTEC, Insulet, IsoRay, Merck, novadipbiosciences, Owens and Minor, rmsmedical, Sanuwave, Visioneering Technologies, Zimmer Biomet

FDA clears device that treats diabetic foot ulcers for market

December 28, 2017 By Danielle Kirsh

The FDA announced today that it has cleared the Dermapace System diabetic foot ulcer treatment device for market. Dermapace System, created by Sanuwave, is the first shockwave device to treat foot ulcers caused by diabetes. “Diabetes is the leading cause of lower limb amputations,” Binita Ashar, director of the division of surgical devices in FDA’s […]

Filed Under: Diabetes, Food & Drug Administration (FDA) Tagged With: Sanuwave

7 medtech stories we missed this week: Sept. 29, 2017

September 29, 2017 By Danielle Kirsh

From EOI getting FDA clearance to Sanuwave’s new joint venture agreement, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. EOI wins FDA nod for FLXfit15 expandable cage EOI announced in a Sept. 28 press release that it has received FDA 510(k) clearance for its FLXfit 15. The clearance […]

Filed Under: Business/Financial News, Clinical Trials, Diagnostics, Food & Drug Administration (FDA) Tagged With: Cefaly, EOI, ivwatch, Lombard Medical, MedTech, Mortise Medical, Mundimed, Sanuwave, Terumo, Varian Medical Systems

7 medtech stories we missed this week: Aug. 18, 2017

August 18, 2017 By Danielle Kirsh

From Nemaura’s new Oceania distribution deal to Sanuwave’s promissory note expansion, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Nemaura inks Oceania distribution deal for SugarBeat patch Nemaura announced in an Aug. 15 press release that it has signed a non-binding distribution deal with Device Technologies for […]

Filed Under: Diabetes, Diagnostics, Implants, Orthopedics, Research & Development, Surgical Tagged With: Brenner Medical, Clinical Innovations, Device Technologies, K2M, Masimo, MedTech, Nemaura Medical, Sanuwave, Si-Bone

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS